Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (<scp>MCL</scp>) ‐ outcomes and mutation profile from venetoclax resistant <scp>MCL</scp> patientsShuangtao Zhao, Preetesh Jain, Guangchun Han et al.|American Journal of Hematology|2020Cited by 84
TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progressionChangying Jiang, Xin Lin, Yifan Zhu et al.|Oncogene|2016Cited by 52
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphomaChangying Jiang, Michael Wang|Journal of Clinical Investigation|2023Cited by 32